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Abstract
Background: Current research aims to develop innovative approaches to improve chondral and osteochondral
regeneration. The objective of this study was to investigate the regenerative potential of platelet-rich plasma (PRP)
to enhance the repair process of a collagen-hydroxyapatite scaffold in osteochondral defects in a sheep model.
Methods: PRP was added to a new, multi-layer gradient, nanocomposite scaffold that was obtained by nucleating
collagen fibrils with hydroxyapatite nanoparticles. Twenty-four osteochondral lesions were created in sheep femoral
condyles. The animals were randomised to three treatment groups: scaffold, scaffold loaded with autologous PRP,
and empty defect (control). The animals were sacrificed and evaluated six months after surgery.
Results: Gross evaluation and histology of the specimens showed good integration of the chondral surface in
both treatment groups. Significantly better bone regeneration and cartilage surface reconstruction were observed
in the group treated with the scaffold alone. Incomplete bone regeneration and irregular cartilage surface
integration were observed in the group treated with the scaffold where PRP was added. In the control group, no
bone and cartilage defect healing occurred; defects were filled with fibrous tissue. Quantitative macroscopic and
histological score evaluations confirmed the qualitative trends observed.
Conclusions: The hydroxyapatite-collagen scaffold enhanced osteochondral lesion repair, but the combination
with platelet growth factors did not have an additive effect; on the contrary, PRP administration had a negative
effect on the results obtained by disturbing the regenerative process. In the scaffold + PRP group, highly
amorphous cartilaginous repair tissue and poorly spatially organised underlying bone tissue were found.
Background
The incidence of articular cartilage lesions has grown
due to the marked increase in sports participation and
greater emphasis on physical activity in all age groups;
patient expectations about recovery have also risen.
Unfortunately, articular chondral defects, with their
inherent limited healing potential, are hard to treat and
remain a challenging problem for orthopaedic surgeons.
Promising results are obtained with the tissue
engineering approach, and matrix-assisted autologous
chondrocyte transplantation is now widely used in Eur-
ope [1,2]. However, the results obtained for the treat-
ment of cartilage lesions are still controversial, and the
treatment of osteo-cartilaginous lesions is even more
problematic because tissue damage also extends to the
sub-chondral bone, involving two different tissues char-
acterised by different intrinsic healing capacities. Several
authors have highlighted the need for biphasic scaffolds
to reproduce different biological and functional require-
ments for guiding the growth of the two tissues, espe-
cially in large osteochondral defect repairs [3,4].
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we tested a recently developed composite scaffold,
composed of Type I collagen and nanostructured
hydroxyapatite (HA), which mimics the biochemical
and biophysical properties of the different layers of
native osteochondral structures [5,6]. This study high-
lighted the promising potential of the graded, biomi-
metic osteochondral scaffold in promoting bone and
cartilage tissue restoration without necessarily includ-
ing autologous cells [6]. In the present study, we tested
if the combination of scaffold and autologous platelet-
rich plasma (PRP) would further improve the good
results previously obtained with the scaffold alone by
increasing the regeneration process of the osteochon-
dral unit. The addition of growth factors (GFs) might
enhance the results and improve scaffold integration
and tissue replacement. PRP is a method that enables
to obtain in a simple, inexpensive and minimally inva-
sive way many autologous growth factors and actually
is widely experimented in different fields of medicine
for its potential in aiding tissue regeneration. The
rationale for the use of PRP in the treatment of many
different tissues is that it provides a reservoir of critical
GFs and cytokines, which govern and regulate the tis-
sue healing process and is quite similar in all kinds of
tissues. In fact, many in vitro studies suggested that
growth factors contained in PRP may be useful for
enhancing both the chondral and osseous component
of the osteochondral regeneration induced by the scaf-
fold. Platelet concentrates play an important role in
the bone tissue reparative processes by stimulating the
initial recruitment of bone marrow cells for migration
[7], mitogenesis, differentiation into osteoblasts, and
angiogenesis [8]. It has also been shown that the addi-
tion of PRP enhances chondral regeneration, enhancing
the proliferation of chondrocytes and improving the
biosynthesis of the cartilage matrix proteins [9,10].
Regarding in vivo studies, so far, few studies have been
performed on PRP for osteochondral regeneration
compared with the extensive work on bone and other
tissue healing [11-13].
The purpose of this experimental study was to evalu-
ate the potential of PRP to enhance the osteochondral
regeneration process induced by the newly developed
collagen-hydroxyapatite scaffold in a sheep model.
Methods
Study design
In the present study, we experimented with two differ-
ent kinds of tissue repair strategies: a) biomimetic scaf-
fold alone (S-Group) and b) biomimetic scaffold
combined with PRP (S-PRP Group). Spontaneous carti-
lage and bone repair was used as control group (C-
Group).
Animal care and surgery were approved by the techni-
cal scientific and ethical committees of our institute and
were performed under national and European regula-
tions (Law by Decree n. 116/92).
Twelve skeletally mature female adult sheep (Berga-
m a s c a - M a s s e s e ,7 0±5k gb . w . )w e r ea c q u i r e df r o m
authorised farms and quarantined for at least 7 days
before use. The animals were randomly divided into 3
groups of 4 animals each according to the treatment
group: S-Group, S-PRP Group and C-Group. A total of
24 osteochondral lesions were performed on the right
medial and lateral femoral condyles, and each animal
received the same treatment on both condyles. Animal-
free movement was permitted immediately after surgery.
After two weeks, the sheep were returned to the exter-
nal stabling fields until the end of the experimental time
(6 months).
Scaffold preparation
The osteochondral (OC) biomimetic scaffold (Fin-Cera-
mica Faenza S.p.A., Faenza-Italy) has a porous, 3-D,
composite, tri-layered structure, mimicking the whole
osteochondral anatomy. The cartilaginous layer, consist-
ing of Type I collagen, has a smooth surface to maintain
joint congruency. The intermediate layer (tidemark-like)
consists of a combination of Type I collagen (60%) and
HA (40%) whereas the lower layer consists of a minera-
lised blend of Type I collagen (30%) and HA (70%),
reproducing the subchondral bone layer (Figure 1).
Each layer of the scaffold is separately synthesised by a
standardised process, starting from an atelocollagen aqu-
eous solution (1% w/w) in acetic acid, isolated from
equine tendon; the upper non-mineralised chondral
layer of the scaffold is obtained by dissolving 200 g of
acetic solution of Type I collagen (Opocrin S.p.A., Corlo
di Formigine, Modena, Italy) in 200 ml of bi-distilled
water after setting the pH at 5.5. By adding 0.1 NaOH,
the precipitate is homogenised by moderate stirring and
rinsed in distilled water. The assembled collagen fibres
are subsequently cross-linked with 42 ml of 0.5 g/L 1,4-
butanediol diglycidyl ether (BDDGE) solution (Fluka,
Sigma-Aldrich Group) and stored at 4°C for 48 hours.
The intermediate and lower layers of the scaffold are
obtained by nucleating bone-like, nanostructured, non-
stoichiometric hydroxyapatite into self-assembling
collagen fibres, as occurs in the natural biological neo-
ossification process [14]. The mineralised intermediate
layer is obtained starting from two reagents prepared as
follows: reagent A, prepared by diluting 300 g of Type I
collagen acetic solution with H3PO4 40 mM, to reach a
final pH of 3.0; reagent B, prepared by mixing 480 ml of
a4 2m MC a ( O H ) 2 solution with 20 ml of 48 mM
MgCl2·6H2O solution and 24 ml of SBF (Simulated
Body Fluid). Under gentle stirring conditions, reagent A
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cles are nucleated into the auto-assembled collagen
fibres, reaching a final pH of 6.0. The obtained precipi-
tate, composed of 60% collagen and 40% of hydroxyapa-
tite, is rinsed in distilled water, cross-linked with 63 mL
of BDDGE cross-linking solution, and stored at 4°C for
48 hours.
The lower layer of the scaffold is also prepared start-
ing from two reagents: reagent C, obtained by adding 40
mM H3PO4 to 200 g of Type I collagen acetic solution,
achieving a pH of 3.0; reagent D, obtained by mixing
1100 ml of 42 mM Ca(OH)2 solution with 50 ml of 48
mM MgCl2·6H2O solution and 55 ml of SBF (Simulated
Body Fluid). Under stirring conditions, reagent C is
dripped into reagent D until the precipitation of HA
into auto-assembled collagen fibres with a final pH of
close to 7.0. The composite precipitate is 70% HA and
30% collagen, respectively. Subsequently, after thor-
oughly rinsing in bi-distilled water, self-assembled col-
lagen HA fibres are cross-linked with 63 mL of BDDGE
solution and then stored at 4° C for 48 hours.
The final construct is obtained by physically combin-
ing the upper, intermediate and lower layers on top of a
Mylar sheet. The three layers are piled up; then, a knit-
ting procedure is applied at each interface (bone-tide-
mark interface and tidemark-cartilage interface) to
assure good integration by the exchange of anchor fibres
between the layers and to avoid delamination at the
interface. Finally, they are freeze-dried and gamma-steri-
lised at 25 KGray [14].
PRP preparation
PRP was prepared according to the method described in
2004 by Weibrich et al. [15] as follows: before each
operation (within about 1 h), approximately 20 ml of
peripheral venous blood was drawn from the radial vein
into siliconised tubes containing 3.8% sodium citrate at
a blood/citrate ratio of 9/1. PRP was obtained by centri-
fugation at 1000 r.p.m. for 5 min.
The number of platelets (PLTs) was determined on
whole blood and on PRP under a microscope with a
haemocytometer after 1/100 dilution with ammonium
oxalate (Unopette1, Becton Dickinson, Milan, Italy). The
% yield was calculated in the following way: (number of
PLTs in PRP/number of PLTs in the whole blood)x100.
The mean ± sd of PLTs number in whole blood was
281 ± 56 × 10
3/μl; after centrifugation the mean number
of PLTs in the PRP was 874 ± 87 × 10
3/μlw i t ham e a n
% yield of 316 ± 36%.
For PLT activation, a 10% solution of CaCl2 (Sigma) in
a5 0μl/ml proportion was added to PRP immediately
before use. Two millilitres of PRP were soaked into the
scaffold.
Aliquots of plasma and PRP were dispensed in Eppen-
dorf tubes for storage at -70°C. Plasma, PRP and PRP
after activation with CaCl2 were assayed for Transform-
ing Growth Factor b1( T G F - b1, ELISA immunoassay,
R&D Systems, MN, USA), Platelet Derived Growth Fac-
tor AB (PDGF-AB, ELISA immunoassay, R&D Systems,
MN, USA), and Interleukin 1 (IL-1, ELISA immunoas-
say, R&D Systems, MN, USA).
Surgical procedure
Surgery was conducted under general anaesthesia fol-
lowing a standardised protocol: pre-medication with 10
mg/kg ketamine i.m. (Ketavet 100, Farmaceutici Gellini
S.p.A., Aprilia, Latina, Italy), 0.3 mg/kg xylazine i.m.
(Rompun Bayer AG, Leverkusen, Germany) and 0.0125
Figure 1 Three-gradient, multi-layer scaffold that mimics the articular osteochondral compartment, reproducing both molecularly and
morphologically cartilage and the subchondral bone layer.
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sodium thiopentone i.v. (2.5%); and maintenance with
O2,N O 2 and 2-3% fluothane (Halothan, Hoechst AG,
Germany) under assisted ventilation (Servo Ventilator
900 D, Siemens, Germany). After medial arthrotomy, a
parapatellar approach to the lateral and medial condyles
was performed, and the condyle was exposed with the
animals in dorsal recumbence and the surgery limb in a
supine and maximally bent position. Then, an osteo-
chondral lesion was made on the medial and lateral
femoral condyles. A specifically designed drill was used
to create a 7-mm diameter and 9-mm thick defect in
the weight-bearing area of both condyles. Grafts were
implanted following the press-fit technique. A total of
sixteen osteochondral grafts were implanted: 8 osteo-
chondral grafts were soaked with PRP at least 5 min
before implantation. Eight lesions were left untreated
and used as controls.
Antibiotics (cephalosporin, 1 g/day for 5 days) and
analgesics (ketoprofen 500 mg/day for 3 days) were
administrated post-operatively, and a veterinarian evalu-
ated the animals’ welfare.
Explanting of samples
All animals were sacrificed 6 months after surgery under
general anaesthesia and by injection of Tanax® (Intervet-
Italia S.r.l., Peschiera Borromeo, Milan, Italy). The stifle
joints were carefully opened; the patellar ligaments were
dorsally reflected; and the joint capsule was macroscopi-
cally evaluated for signs of inflammation, such as tissue
reddening, hypertrophy of the villous part of the syno-
vial membrane, tissue adhesions, appearance of a fat
pad, and clearness and colour of the synovial fluid. Both
condyles of the joint were carefully exposed, thus pre-
serving the surface of the operation in the medial and
lateral areas. The newly formed tissue in the areas of
scaffold implantation was macroscopically assessed. The
cartilage surface was evaluated for position, surface and
staining of the implanted areas and the implant-host
cartilage interface. Obvious signs of matrix degradation,
such as fibrillation, cleft formation, cobble stone appear-
ance, and discoloration of the hyaline cartilage surface
were recorded and compared among groups. Each
explanted knee was cut into medial and lateral condyles.
Subsequently, the areas of the operation were carefully
removed, paying attention also when removing portions
of healthy cartilage surrounding the lesion. The macro-
scopic appearance of the implants and the quality of
healing were blindly assessed using a modified scoring
system from Fortier [16] that analyses surface texture of
repair tissue, percent area of the defect filled, and graft-
recipient tissue integration. The score was modified to
add the bone-cartilage appearance and bone-defect fill-
ing evaluation. We also made a gross morphological
evaluation using a scoring system proposed by Nieder-
auer [17], focusing on edge integration, smoothness of
the cartilage surface, cartilage degree of filling, and col-
our of the cartilage.
Sample preparation and histological evaluation
Each medial and lateral sample was cut in half along the
central axis of the implant. Half remained undecalcified
and were processed for resin embedding; half were dec-
alcified and embedded in paraffin. The latter samples
were fixed in 10% formalin-buffered solution for 72
hours and decalcified in a nitric/formic acid solution.
When decalcification was complete, the samples were
dehydrated in a graded series of alcohols from 70% to
absolute and then processed for paraffin embedding.
Four-micrometer-thick sections were obtained by a
Microm HM340E (Microm International GmbH, Hei-
delberg, Germany) and stained with toluidine blue, fast
green and haematoxilin/eosin or safranin-O, fast green
and toluidine blue.
The specimens of undecalcified bone processing his-
tology were first fixed in 4% buffered paraformaldehyde
for 48 hours, then dehydrated in graded series of alco-
hols until the absolute was reached. Finally, they were
embedded in an epoxy resin (Struers Co. Copenhagen,
Denmark). Blocks were sectioned along a plane parallel
to the long axis of the osteochondral transplant. A series
of 200 ± 10-μm thick sections, spaced 300 μma p a r t
(due to a microtome diamond saw thickness), was
obtained with a Leica 1600 diamond saw microtome
(Leica SpA, Milan, Italy). Then, sections were thinned to
30 ± 10 μm and stained with safranin-O/fast green and
acid fuchsin. Microradiography evaluations were per-
formed on 100 ± 10-μm sections, and images were
acquired by high resolution photo-emulsion plates
(exposition: 30 seconds, 20 kV).
The sections were processed for routine histological
analysis by using a transmission and polarised light
Axioskop Microscope (Carl Zeiss GmbH, Jena, Ger-
many) and a computerised image analysis system with
Kontron KS 300 software (Kontron Electronic GmbH,
Eiching bei Munchen, Germany). After light microscopy
evaluation at different magnifications, bone measure-
ments were taken semi-automatically by 2 blinded inves-
tigators at a magnification of 10×. The histology was
assessed using the score proposed by Niederauer [17].
Immunohistochemical analysis
The sections of decalcified and paraffin-embedded sam-
ples were deparaffinised, incubated with trypsin 0.1% for
20 min at 37°C, and then incubated with goat serum
diluted 1:20 for 10 min. The specimens were then incu-
bated for 1 hour at room temperature with a primary
monoclonal antibody against type II collagen (clone
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more, MD) or for 24 hours at 4°C with a primary mono-
clonal antibody against type I collagen (Quartett, Berlin,
Germany). The slides were then incubated with a bioti-
nylated goat anti-mouse secondary antibody (Dako, Car-
penteria, CA) for 35 min. Finally, the avidin-biotin
complex coupled with alkaline phosphatase (ABC/AP
complex, Dako, Carpenteria, CA) was used for the stain-
ing according to the manufacturer’s instructions fol-
lowed by incubation with fast red substrate and
levamisole (Dako, Carpenteria, CA) and counterstaining
with haematoxylin/eosin.
Statistical analysis
Statistical analysis was performed by SPSS 15.0. Data
were expressed in terms of mean ± SD at a significance
level of p < 0.05. The non-parametric Kruskal-Wallis
test or Mann-Whitney tests, followed by the Monte
Carlo methods to compute probability, were used to
analyse data.
Results
Platelet growth factors
The results of TGF-b1 (activated fraction), PDGF-AB
and IL-1 was 53 ± 7, 62 ± 14, 1.6 ± 0.4 ng/ml in plasma,
113 ± 28, 87 ± 11, 3.3 ± 0.4 ng/ml in PRP and 453 ±
110, 232 ± 85, 9.7 ± 5 ng/ml in PRP activated with
CaCl2, respectively.
Gross appearance and macroscopic evaluation
All animals tolerated surgery well and survived the post-
surgical period. Gait was completely normal without a
severe limp, and the joints appeared stable. All sheep
showed soft tissue swelling of the treated joints. There
were no signs of synovitis. No signs of fracture were
detected on post-operative and pre-operative X-Ray
examination.
The joint inspection revealed the absence of joint
inflammation, adhesions between the joint capsule, fat
pad and collateral joint compartment. A slightly
hyperemic synovium was observed in the majority of
cases. No synovial hypertrophy or fibrosis was noted.
All grafts were still in their original location. Small
osteophytes were detected in the medial condyles of all
groups.
Gross evaluation of specimens showed that no bone
and cartilage defect healing occurred in the control
group (Figure 2A). Good integration of the healthy
chondral surface, newly formed hyaline-like tissue and
better bone regeneration were observed in the group
implanted with the scaffold alone (S-Group) (Figure 2C)
whereas incomplete bone defect filling and irregularity
of the bone-cartilage surface were detected in the S-PRP
Group (Figure 2B).
Evaluation of the macroscopic appearance with the
modified Fortier [16] and Niederaurer [17] scores
showed better results in both experimental groups com-
pared with the control group. However, the S-Group
achieved marked improvement with a highly statistically
significant difference (p < 0.0005), whereas the group
with PRP added to the scaffold obtained lower improve-
ment with a lower statistically significant difference
compared with the untreated group (p = 0.018 for the
Niederauer score and p= 0.024 for the modified Fortier
score) (Figures 3, 4) (Table 1).
Microradiographic evaluation
Microradiographic evaluation highlighted the appear-
ance of newly formed bone in the deepest area of the
osteochondral implant (Figure 2): an improvement in
subchondral bone healing was observed in both experi-
mental groups compared with the control. Better bone
regeneration in the S-Group compared with the S-PRP
Group was confirmed (Figure 2). No bone growth in the
chondral layer was observed in any group.
Histological evaluation
Histological assessment confirmed the macroscopic
results (Figure 2). No bone and cartilage defect healing
occurred in the control group; the defect was filled with
amorphous fibrous tissue. Both experimental groups dis-
played significantly superior histological results com-
pared with the control group. Comparing the
experimental groups, worse results were observed in the
S-PRP Group (p = 0.036) (Figures 5, 6). Neither an
inflammatory reaction nor giant cells were observed in
the grafted area, and complete reabsorption of the
implanted biomaterial was detected. Histological evalua-
tion showed the presence of newly formed repair tissue
and good integration of the scaffolds with the host carti-
l a g ef o rt h eS - G r o u p .T h ep r e s e n c eo fan e w l yf o r m e d
hyaline-like tissue with strong proteoglycan staining and
the columnar rearrangement of chondrocytes were
observed (Figure 6). An underlying, well-structured, sub-
chondral trabecular bone, distinguishable from the
healthy adjacent bone, was also noted. Also better bone
regeneration was observed in the S-Group compared
with the S-PRP group where incomplete bone defect fill-
ing and irregularity of the bone-cartilage surface were
detected.
Immunohistochemical staining for collagen types I and
II generally confirmed the histological evaluation. The S-
Group displayed an orderly pattern of tissue repair with
type II collagen staining positive in the cartilaginous
layer down to the interface with the subchondral bone,
and type I collagen staining uniformly positive in the
subchondral tissue or associated with single cells in the
chondral region (Figure 7 C, F). The subchondral tissue
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lagen; the hypertrophic chondrocyte morphology sug-
gested ongoing remodelling towards a bone matrix.
Instead, in the S-PRP and C-Groups, type II collagen
staining was either negative or positive in scattered
areas whereas a positive staining for type I collagen in
the extracellular matrix was extended throughout the
repair tissue up to the joint space (Figure 7 A, B, D, E).
Discussion
The aim of this study was to evaluate the potential of
autologous PRP to enhance the osteochondral regenera-
tion process induced by a newly developed biphasic
scaffold in a sheep model.
The sheep model was chosen for the current experi-
ment because limb-loading in the sheep is comparable
to that of humans and more similar than the rabbit
model to the human one. Even if many questions on tis-
sue regeneration can be answered in relatively simple
models, in small animals, the level of the load cannot be
a critical factor for the success of a tissue-engineered
procedure. It is generally agreed that the results
obtained in large animals are more representative of the
clinical situation. Final pre-clinical tests in large animals
present relevant loading conditions and allow the adop-
tion of a surgical technique similar to the final proce-
dure used in humans [13,18].
Both lateral and medial condyle defects underwent the
same treatments to avoid the possible influence on
defect healing among the investigated treatments. In
addition, as reported by other authors, both defects
were created on the same knee to allow the sheep to
unload the operated limbs for the first post-operative
week [19]. In agreement with other researchers and our
previous experiences, no difference in regeneration
between the medial and lateral condyles was observed
although it is known that the medial compartment of
the knee sustains higher loads than the lateral one [20].
As also shown in a previous study [6] with the same
animal model, osteochondral defects treated with a scaf-
fold alone showed the appearance of a newly formed
cartilaginous mantle similar but not equal to the native
hyaline cartilage. We must keep in mind that the
kinetics of cartilaginous and bone regrowth certainly
Figure 2 Macroscopic, micro X-ray and histological evaluations at 6 months of the C-Group (A), S-PRP Group (B), S-Group (C).
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connective tissue repair were probably still in evolution
at the time of evaluation. However, the 6-month follow-
up was evidently sufficient to provide clear indications
of the ongoing regenerative processes. Whereas the
results indicated poor spontaneous healing of the osteo-
chondral defect in this sheep model, the implant of the
gradient biomimetic scaffold led to the reconstruction of
the hyaline-like cartilage and the structured bone tissue
anchored to the interface of adjacent healthy tissues.
Healing of the deep osteochondral defect was evident:
histological images excluded the presence of bone tissue
inside the upper cartilaginous layer and, from a histolo-
gical viewpoint, no inflammatory reactions were
observed at any of the treatment sites. Moreover, osteo-
chondral defects treated with the biphasic scaffold had
the appearance of a newly formed cartilaginous mantle
similar to the native hyaline cartilage.
Although the marked regrowth observed of good qual-
ity subchondral bone characterised by well-defined cor-
tex, in some other areas osteoid tissue appeared to be
still distinguishable, and also the cartilage regenerative
process was partial with the presence of only hyaline-
like cartilage. To further improve the osteochondral
regeneration capacity of this 3-layered, biomimetic,
nanostructured scaffold, the addition of bioactive agents
was experimented aiming to speed the reparative pro-
cess and led to a higher tissue quality. PRP is a recently
developed, promising method that provides an easy, safe
and cost-effective way to obtain various GFs, which
have been shown in vitro to increase chondrocyte prolif-
eration and differentiation markers [9,10]. Wu et al. also
hypothesised that the multiple GFs contained in PRP
could have a synergistic effect on osteoblasts, which
should improve proliferation and synthesis of bone mar-
row precursors and improve the integration of regener-
ated cartilage and underlying bone tissue [11].
Surprisingly, despite the in vitro premises and the
positive theoretical assumptions, the results of this study
s h o w e dn o to n l yt h el a c ko fap o s i t i v ee f f e c tb u te v e na
negative influence of autologous PRP on bone and carti-
lage regeneration. Findings of our research were a highly
Figure 3 Comparison of scores obtained with the modified Fortier evaluation of gross appearance (max 0-min 15).
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spatially organised underlying bone tissue.
Analysing the literature on chondral and osteochon-
dral tissue regeneration, few studies have been per-
formed until now although there have been several
papers about bone healing. In a rabbit model, Sun et al.
demonstrated that the addition of PRP to a scaffold
made of polyglycolic acid had a significantly positive
effect on osteochondral formation [12]. In a goat model,
Brehm et al. evaluated the repair of osteochondral
defects with an autologous scaffold-free cartilage con-
struct alone and with the addition of PRP as an adhesive
to secure the implant or to cover the overlying perios-
teal flap [13]. Even if their study was aimed at evaluating
different implantation modalities, they found that PRP
did not improve integration of the implant. Moreover,
when PRP was used in combination with a periosteal
flap, it was less effective than the periosteal flap alone.
Finally, PRP alone also caused intensive bone remodel-
ling of the subchondral bone [13].
These heterogeneous findings are certainly difficult to
explain, but in the most investigated field of bone heal-
ing, discordant results have been obtained when PRP
was added to various biological and synthetic biomater-
ials. No advantages on the combination of hydroxyapa-
tite, beta-tricalcium phosphate and PRP were reported
in experimental studies in the early phase of bone
Figure 4 Comparison of scores obtained with the Niederauer evaluation of gross appearance (max 8-min 0).
Table 1 Macroscopic appearance of the implants and the
quality of healing assessed using a modified scoring
system from Fortier and a scoring system proposed by
Niederauer
Fortier score (max 0-min 15) Niederauer score (max 8-min 0)
C-Group S-PRP Group S-Group C-Group S-PRP Group S-Group
11 7 6 3 5 6
12 3 4 3 6 5
15 5 1 0 5 7
15 14 1 0 1 5
14 5 3 2 5 6
732 475
15 9 4 0 4 6
14 3 0 0 7 7
12.86 6.13 2.63 1.50 5.00 5.88
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e f f e c t sw h e nP R Pw a sa d d e dt oe n d o s s e o u si m p l a n t s
both in cortical and trabecular bone [15,22,23]. Mechan-
ical trauma due to high pressure after gel application in
press-fit implant surgery has been hypothesised [23] as a
negative factor that may compromise the final outcome.
Better results have been obtained from other authors
using PRP, but the effects depended on the implant che-
mical surface, being more effective when applied on
metallic surfaces, whereas to a lesser extent on ceramic
surfaces [23-27].
Analysis of the results obtained in the different experi-
ments reported in the literature is complicated. In fact,
when discussing PRP, several variables have to be con-
sidered. Although our interest was not to afford the bio-
logical variables linked to PRP therapy, the following
considerations are highlighted. These variables mainly
depend on the methods of PRP preparation and conser-
vation, the type of activators, the type of pathology trea-
ted, the dose used, and the mode and times of
administration. The regulation of tissue healing and
regeneration is a complex process, and even small differ-
ences in the amount of growth factors administered can
lead to the opposite results. As Weibrich [15] reported,
the PLT concentration required for a positive PRP effect
on bone regeneration spanned a limited range. An
advantageous biological effect seemed to occur when
PRP with a PLT concentration of approximately 1
6/
microl was used. At lower concentrations, the effect was
suboptimal, whereas higher concentrations had a para-
doxically inhibitory effect. Moreover, as in this case, the
combination of PRP with other treatments further com-
plicate the interpretation of the results. The reasons for
the contradictory findings about the influence of PRP
on the regenerative potential of scaffolds are not com-
pletely understood although some hypotheses have been
advanced. Some mechanisms have been proposed to
determine the success or the failure of the treatment:
the presence of collagen on experimental biomaterials
(both calcium phosphate and hydroxyapatite) induces in
vitro the activation of PLTsa n dG Fr e l e a s e[ 2 8 ] ;t h e
specific surface area of rough and porous materials
Figure 5 Comparison of scores obtained with the Niederauer histologic scoring scale for osteochondral defects (max 28-min 0).
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Page 9 of 12modulates PRP absorption and causes increased degra-
nulation and release of the GFs from the PLTs [29]; a
fibrous tissue and a foreign body giant cell reaction,
which was observed when PRP was added to synthetic
biomaterials, might be due to the presence of TGF,
which also supports fibroblast chemotaxis [30]. Regard-
ing these hypotheses, it is possible that the implant sur-
face and chemical composition influence the format in
which GFs are delivered and the time course of delivery
during the early inflammatory phases. GFs can also
affect the scaffold through the stimulation of cell resorp-
tion of the implants. Moreover, the presence of areas
within the subchondral compartment that positively
stained for type II collagen, including cells with hyper-
trophic chondrocyte morphology, suggests that the scaf-
fold-mediated regeneration of subchondral bone
followed an endochondral ossification process. To this
purpose, Ranly et al. observed that PDGF and PLT gel
reduced heterotopic bone formation (usually through
endochondral ossification) after muscle implantation of
demineralised bone matrix (DBM) even in the presence
of DBM with a proven osteoinductive ability [31,32].
These authors also observed that GFs stimulate osteo-
clast resorption of the implants. Finally, we might also
argue that the high content of angiogenic growth factors
in PRP can delay and disturb cartilage regeneration and
maturation with time.
From our findings, we deduce that PRP does not
enhance the osteochondral regeneration capability of a
collagen-hydroxyapatite scaffold in this sheep model. On
the contrary, by negatively interfering with the regenera-
tive process, the bioactive factors in the PLT concen-
trate produced worse results than those obtained from
the use of the scaffold alone. It is possible that different
PRP preparation techniques, doses and application mod-
alities produce different and better results.
Conclusion
Current research aims to develop innovative approaches
to improve chondral and osteochondral regeneration. In
this study, we tested if the addition of PRP would
further improve the good results previously obtained
with a newly developed biphasic scaffold alone by
increasing the regeneration process of the osteochondral
unit. PRP seems to be an ideal vehicle to provide
numerous growth factors, and it has been widely experi-
mented on worldwide in numerous fields because of its
potential to facilitate the healing process. However, our
findings demonstrated that this administration modality
in the sheep model may negatively interfere with
tissue regeneration. Therefore, we conclude that, even if
Figure 6 Histological evaluation at 6 months of undecalcified
samples of the C-Group (A), S-PRP Group (B), S-Group (C).
Staining with fuchsin acid/fast green/toluidine blue, 10×
magnification.
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Page 10 of 12theoretically useful for many treatments, PRP has to be
carefully considered before its use in humans; the risk of
negative effects and the role of many variables that may
influence the final outcome need to be clarified to
obtain better results and optimise the potential benefits
of this technique.
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